HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clara cell secretory protein in tracheobronchial aspirates and umbilical cord serum of extremely premature infants with systemic inflammation.

AbstractBACKGROUND:
A systemic fetal inflammatory response, reflected by chorioamnionitis with funisitis, is a risk factor for bronchopulmonary dysplasia. Clara cell secretory protein (CC10), a product of pulmonary Clara cells, has anti-inflammatory properties. Local down-regulation of CC10 has been associated with inflammatory lung disease. Increased serum levels of CC10 can indicate injury to alveolar-capillary integrity.
OBJECTIVE:
We hypothesized that extremely premature infants with a systemic fetal inflammatory response would have decreased concentrations of CC10 in tracheobronchial aspirates and that CC10 concentrations in umbilical cord serum of these infants would be increased, reflecting alveolar epithelial damage.
METHODS:
We measured CC10 concentrations in tracheobronchial aspirates of 42 ventilated extremely premature infants during their first week of life and in umbilical cord serum of 24 of them by ELISA. Standardized histological examination of the placenta, membranes and umbilical cord was used to identify infants with funisitis.
RESULTS:
Seventeen infants with funisitis had lower CC10 concentrations in tracheobronchial aspirates on days 1 (p < 0.01) and 3 (p < 0.05) than the remaining 25. Exogenous surfactant treatment was associated with higher CC10 concentrations on day 1 (p < 0.05). Initial leukocyte count correlated inversely with CC10 in tracheobronchial aspirates on days 1-5. Umbilical cord serum concentrations of CC10 did not differ between the infants with funisitis and the controls.
CONCLUSIONS:
Reduced anti-inflammatory CC10 concentrations in airways of extremely premature infants with a fetal inflammatory response might make their lungs susceptible for further postnatal injuries. Umbilical cord serum CC10 is not an indicator for a fetal systemic inflammatory reaction.
AuthorsWolfgang Thomas, Silvia Seidenspinner, Natalia Kawczyńska-Leda, Maria Chmielnicka-Kopaczyk, Alexander Marx, Johannes Wirbelauer, Marta Szymankiewicz, Christian P Speer
JournalNeonatology (Neonatology) Vol. 97 Issue 3 Pg. 228-34 ( 2010) ISSN: 1661-7819 [Electronic] Switzerland
PMID19887851 (Publication Type: Journal Article)
CopyrightCopyright 2009 S. Karger AG, Basel.
Chemical References
  • SCGB1A1 protein, human
  • Uteroglobin
Topics
  • Body Fluids (chemistry)
  • Bronchi (metabolism)
  • Bronchopulmonary Dysplasia (blood, metabolism)
  • Female
  • Fetal Blood (chemistry, metabolism)
  • Gestational Age
  • Humans
  • Infant, Extremely Low Birth Weight (blood, metabolism)
  • Infant, Newborn
  • Infant, Premature (blood, metabolism)
  • Infant, Premature, Diseases (blood, metabolism)
  • Male
  • Osmolar Concentration
  • Respiration, Artificial
  • Serum (chemistry, metabolism)
  • Suction
  • Systemic Inflammatory Response Syndrome (blood, metabolism)
  • Trachea (metabolism)
  • Uteroglobin (analysis, blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: